Use of sodium iodide symporter expression in differentiated thyroid carcinomas (2011)
Source: Clinical Endocrinology. Unidade: FO
Subjects: SÓDIO, IODO, CARCINOMA, DOENÇAS DA TIREOIDE, ENDOCRINOLOGIA
ABNT
MORARI, Elaine C et al. Use of sodium iodide symporter expression in differentiated thyroid carcinomas. Clinical Endocrinology, p. 247-254, 2011Tradução . . Disponível em: https://doi.org/10.1111/j.1365-2265.2011.04032.x. Acesso em: 12 set. 2024.APA
Morari, E. C., Marcello, M. A., Guilhen, A. C. T., Cunha, L. L., Latuff, P., Soares, F. A., et al. (2011). Use of sodium iodide symporter expression in differentiated thyroid carcinomas. Clinical Endocrinology, 247-254. doi:10.1111/j.1365-2265.2011.04032.xNLM
Morari EC, Marcello MA, Guilhen ACT, Cunha LL, Latuff P, Soares FA, Ward LS, Vassallo J. Use of sodium iodide symporter expression in differentiated thyroid carcinomas [Internet]. Clinical Endocrinology. 2011 ; 247-254.[citado 2024 set. 12 ] Available from: https://doi.org/10.1111/j.1365-2265.2011.04032.xVancouver
Morari EC, Marcello MA, Guilhen ACT, Cunha LL, Latuff P, Soares FA, Ward LS, Vassallo J. Use of sodium iodide symporter expression in differentiated thyroid carcinomas [Internet]. Clinical Endocrinology. 2011 ; 247-254.[citado 2024 set. 12 ] Available from: https://doi.org/10.1111/j.1365-2265.2011.04032.x